Pharmacoeconomic assessment of propofol 2% used for prolonged sedation

ObjectiveTo demonstrate that the use of propofol 2% is comparable to propofol 1% in effectiveness and in the wake-up time used for prolonged sedation.DesignOpen-label, case cohort study with a cohort of historical controls, phase IV clinical trial.SettingMedical and surgical intensive care unit (ICU